Company intelligence / Profile preview

Akadeum Life Sciences

Ann Arbor, Michigan, United Statesakadeum.com ↗

Ownership: Private
Development stage: Commercial

Overview

Akadeum’s BACS™ microbubble platform has demonstrated improved yields, higher viability, and gentler processing compared to conventional methods. The company’s products have been adopted in preclinical animal models supporting cancer treatment workflows. Recent launches include GMP-compliant kits now used by biopharma partners entering clinical trials. Customer data show high-impact results in cell therapy manufacturing settings.

Therapeutic areas: Oncology
Modalities: Cell therapyNucleic acid extractionProtein separation
Industry: Non-Drug Biotech

Partnerships

CatalentCharles River LaboratoriesElevateBioLonza

Beyond the preview

Go deeper on Akadeum Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akadeum Life Sciences.

Explore the full profile